Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase

Cancer Research

Volumn 60, Issue 9, 2000, Pages 2365-2367

  Banerjee, Debabrata ^a   Gorlick, Richard ^a   Liefshitz, Anna ^a   Danenberg, Kathy ^b   Danenberg, Peter C ^b   Danenberg, Peter V ^b   Klimstra, David ^a   Jhanwar, Suresh ^a   Cordon Cardo, Carlos ^a   Fong, Yuman ^a   Kemeny, Nancy ^a   Bertino, Joseph R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; DNA TOPOISOMERASE; FLUOROPYRIMIDINE; FLUOROURACIL; THYMIDYLATE SYNTHASE; TRANSCRIPTION FACTOR E2F;

ARTICLE; CANCER RESISTANCE; COLON CANCER; CONTROLLED STUDY; ENZYME RELEASE; FIBROSARCOMA; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LUNG METASTASIS; PRIORITY JOURNAL; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADENOCARCINOMA; BLOTTING, WESTERN; CARRIER PROTEINS; CELL CYCLE PROTEINS; COLONIC NEOPLASMS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LUNG NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYMIDYLATE SYNTHASE; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS;

EID: 0034192487     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Kemeny, N., and Ron, I. G. Hepatic arterial chemotherapy in metastatic colorectal patients. Semin. Oncol., 26: 524-535, 1999.
2. Moertel, C. G., and Reitemeier, R. J. Clinical features influencing therapeutic response to fluorinated pyrimidines. In: C. G. Moertel and R. J. Reitemeier (eds.), Advanced Gastrointestinal Cancer - Clinical Management and Chemotherapy, pp. 122-125. New York: Harper & Row, 1969.
3. Girard, P., Ducreux, M., Baldeyrou, P., Rougier, P., LeChevalier, T., Bougaran, J., Lasser, P Gayet, B., Ruffle, P., and Grunenwald, D. Surgery for lung metastases from colorectal cancer: analysis of prognostic factors. J. Clin. Oncol., 14: 2047-2053, 1996.
4. Poon, M. A., O'Connell, M. J., Moertel, C. G., Wieand, H. S., Cullinan, S. A., Everson, L. K., Krook, J. E., Mailliard, J. A., Laurie, J. A., and Tschetter, L. K., on behalf of the North Central Cancer Treatment Group, Saskatchewan Cancer Foundation, Regina, Canada. Biochemical modulation of fluorouracil. Evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J. Clin. Oncol., 7: 1407-1414, 1989.
5. Lenz, H. J., Leichman, C. G., Danenberg, K. D., Danenberg, P. V., Groshen, S., Cohen, H., Laine, L., Crookes, P., Silberman, H., Baranda, J., Garcia, Y., Li, J., and Leichman, L. Thymidylate synthase m RNA level in adenocarcinoma of the stomach: a predictor of primary tumor response and overall survival. J. Clin. Oncol., 14: 176-182, 1996.
6. Leichman, L., Lenz, H. J., Leichman, C. G., Danenberg, K., Baranda, J., Groshen, S., Boswell, W., Metzger, R., Tan, M., and Danenberg, P. V. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal response and resistance to protracted infusion of fluorouracil and weekly leucovorin. J. Clin. Oncol., 15: 3223-3229, 1997.
7. Johnston, P. G., Lenz, H. J., Leichman, C. G., Danenberg, K. D., Allegra, C. J., Danenberg, P. V., and Leichman, L. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res., 55: 1407-1412, 1995.
8. Lenz, H. J., Hayashi, K., Salonga, D., Danenberg, K. D., Danenberg, P. V., Metzger, R., Banerjee, D., Bertino, J. R., Groshen, S., Leichman, L. P., and Leichman, C. P. p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival. Clin. Cancer Res., 4: 1243-1250, 1998.
9. Aschele, C., Debernardis, D., Casazza, S., Antonelli, G., Baldo, C., Lionetto, R., Maley, F., and Sobrero, A. Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy. J. Clin. Oncol., 17: 1760-1767, 1999.
10. Gorlick, R., Metzger, R., Danenberg, K. D., Salonga, D., Miles, J. S., Longo, G. S. A., Fu, J., Banerjee, D., Klimstra, D., Jhanwar, S., Danenberg, P. V., Kemeny, N., and Bertino, J. R. Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma. J. Clin. Oncol., 16: 1465-1469, 1998.
11. 1 S-regulatory genes. Mol. Cell. Biol., 15: 4215-4224, 1995.
12. DeGregori, J., Leone, G., Miron, A., Jakoi, L., and Nevins, J. R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA, 94: 7245-7250, 1997.
13. Chellappan, S. P., Hiebert, S., Mudryj, M., Horowitz, J. M., and Nevins, J. R. The E2F transcription factor is a cellular target for the RB protein. Cell, 65: 1053-1061, 1991.
14. Ikeda, M-A., Jakoi, L., and Nevins, J. R. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA, 93: 3215-3220, 1996.
15. Banerjee, D., Schnieders, B., Fu, J. Z., Adhikari, D., Zhao, S-C., and Bertino, J. R. Role of E2F-1 in chemosensitivity. Cancer Res., 58: 4292-4296, 1998.
16. ARF links the tumor suppressors RB and p53. Nature (Lond.), 395: 124-125, 1998.
17. DeMuth, J. P., Jackson, C. M., Waever, D. A., Crawford, E. L., Durzinsky, D. S., Durham, S. J., Zaher, A., Phillips, E. R., Khuder, S. A., and Willey, J. C. The gene expression index c-myc xE2F-1/p21 is highly predictive of malignant phenotype in human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol., 19: 18-24, 1998.
18. Parr, M. J., Manome, Y., Tanaka, T., Wen, P., Kufe, D. W., Kaelin, W. G. and Fine, H. A. Tumor selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector. Nat. Med., 3: 1145-1149, 1997.